Rifat Pamukcu
Net worth: 16 529 $ as of 2026-05-30
Net worth: 16 529 $ as of 2026-05-30
Rifat Pamukcu is the founder of Cell Pathways, Inc. Current jobs include Chairman, President & Chief Executive Officer at Midway Pharmaceuticals, Inc. since 2005, President & Chief Executive Officer at Atrin Pharmaceuticals LLC, Chief Executive Officer & Director at RxMP Therapeutics, Inc. since 2016, Director at Virion Therapeutics LLC since 2018, Independent Director at Aprea Therapeutics, Inc. since 2022, Director at Syantra, Inc. since 2019, Director at SIRPant Immunotherapeutics, Inc. since 2021, and Managing Partner at Corami LLC since 2016.
Former job includes Director at Atrin Pharmaceuticals, Inc. Education includes an undergraduate degree from The Johns Hopkins University and a doctorate from the University of Wisconsin.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-20 | 18,509 ( 0.15% ) | 16 529 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| APREA THERAPEUTICS, INC. | Director/Board Member | 2022-04-30 |
Midway Pharmaceuticals, Inc.
Midway Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops non-antibiotic therapies | Chief Executive Officer | 2004-12-31 |
Atrin Pharmaceuticals LLC
Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Engages in discovery and development of proprietary medications | Chief Executive Officer | - |
RxMP Therapeutics, Inc.
RxMP Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and designs novel hemostatic agents to arrest or prevent excessive bleeding | Chief Executive Officer | 2015-12-31 |
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Develops chronic viral disease vaccines | Director/Board Member | 2017-12-31 |
SIRPant Immunotherapeutics, Inc.
SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops adoptive cell therapy | Director/Board Member | 2020-12-31 |
Corami LLC | Corporate Officer/Principal | 2015-12-31 |
Syantra, Inc.
Syantra, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which provides cancer diagnosis services | Director/Board Member | 2018-12-31 |
| Companies | Position | End |
|---|---|---|
Cell Pathways, Inc.
Cell Pathways, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat cancer | Founder | 2002-12-31 |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 12 |
|---|---|
Cell Pathways, Inc.
Cell Pathways, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat cancer | Health Technology |
Midway Pharmaceuticals, Inc.
Midway Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops non-antibiotic therapies | Health Technology |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atrin Pharmaceuticals LLC
Atrin Pharmaceuticals LLC BiotechnologyHealth Technology Engages in discovery and development of proprietary medications | Health Technology |
RxMP Therapeutics, Inc.
RxMP Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and designs novel hemostatic agents to arrest or prevent excessive bleeding | Health Technology |
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Develops chronic viral disease vaccines | Health Technology |
Aprea Therapeutics, Inc.
Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
Syantra, Inc.
Syantra, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which provides cancer diagnosis services | Commercial Services |
SIRPant Immunotherapeutics, Inc.
SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops adoptive cell therapy | Health Technology |
Atrin Pharmaceuticals, Inc.
Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Health Technology |
Corami LLC |
Select your edition
All financial news and data tailored to specific country editions